| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| LIPROLOG MIX50 KWIKPEN 100U/ml | INSULINUM LISPRO | SUSP. INJ. | A10AD04 | W53317002 | ELI LILLY NEDERLAND BV - OLANDA | X | |||||
| LIPROLOG MIX25 KWIKPEN 100U/ml | INSULINUM LISPRO | SUSP. INJ. | A10AD04 | W53316001 | ELI LILLY NEDERLAND BV - OLANDA | X | |||||
| LIPROLOG MIX25 KWIKPEN 100U/ml | INSULINUM LISPRO | SUSP. INJ. | A10AD04 | W53316002 | ELI LILLY NEDERLAND BV - OLANDA | X | |||||
| LIPROLOG KWIKPEN100U/ml | INSULINUM LISPRO | SOL. INJ. | A10AB04 | W53909001 | ELI LILLY NEDERLAND BV - OLANDA | X | |||||
| LIPROLOG KWIKPEN100U/ml | INSULINUM LISPRO | SOL. INJ. | A10AB04 | W53909002 | ELI LILLY NEDERLAND BV - OLANDA | X | |||||
| LIPOFUNDIN MCT/LCT 200 mg/ml | COMBINATII (LIPIDE) | EMULSIE PERF. | B05BA02 | W10045003 | B. BRAUN MELSUNGEN AG - GERMANIA | ||||||
| LIPOFUNDIN MCT/LCT 200 mg/ml | COMBINATII (LIPIDE) | EMULSIE PERF. | B05BA02 | W10045004 | B. BRAUN MELSUNGEN AG - GERMANIA | ||||||
| LIPOFUNDIN MCT/LCT 200 mg/ml | COMBINATII (LIPIDE) | EMULSIE PERF. | B05BA02 | W10045005 | B. BRAUN MELSUNGEN AG - GERMANIA | ||||||
| LIPOFUNDIN MCT/LCT 200 mg/ml | COMBINATII (LIPIDE) | EMULSIE PERF. | B05BA02 | W10045006 | B. BRAUN MELSUNGEN AG - GERMANIA | ||||||
| LIPOFIB 160 mg | FENOFIBRATUM | CAPS. | C10AB05 | W43325001 | TERAPIA SA - ROMANIA | ||||||
| LIPOFIB 160 mg | FENOFIBRATUM | CAPS. | C10AB05 | W43325002 | TERAPIA SA - ROMANIA | ||||||
| LIPOCOMB 40 mg/10 mg | COMBINATII (ROSUVASTATINUM+EZETIMIBUM) | CAPS. | C10BA06 | W61296001 | EGIS PHARMACEUTICALS PLC - UNGARIA | ||||||
| LIPOCOMB 40 mg/10 mg | COMBINATII (ROSUVASTATINUM+EZETIMIBUM) | CAPS. | C10BA06 | W61296002 | EGIS PHARMACEUTICALS PLC - UNGARIA | ||||||
| LIPOCOMB 40 mg/10 mg | COMBINATII (ROSUVASTATINUM+EZETIMIBUM) | CAPS. | C10BA06 | W61296003 | EGIS PHARMACEUTICALS PLC - UNGARIA | ||||||
| LIPOCOMB 40 mg/10 mg | COMBINATII (ROSUVASTATINUM+EZETIMIBUM) | CAPS. | C10BA06 | W61296004 | EGIS PHARMACEUTICALS PLC - UNGARIA | ||||||
| LIPOCOMB 40 mg/10 mg | COMBINATII (ROSUVASTATINUM+EZETIMIBUM) | CAPS. | C10BA06 | W61296005 | EGIS PHARMACEUTICALS PLC - UNGARIA | ||||||
| LIPOCOMB 40 mg/10 mg | COMBINATII (ROSUVASTATINUM+EZETIMIBUM) | CAPS. | C10BA06 | W61296006 | EGIS PHARMACEUTICALS PLC - UNGARIA | ||||||
| LIPOCOMB 40 mg/10 mg | COMBINATII (ROSUVASTATINUM+EZETIMIBUM) | CAPS. | C10BA06 | W61296007 | EGIS PHARMACEUTICALS PLC - UNGARIA | ||||||
| LIPOCOMB 20 mg/10 mg | COMBINATII (ROSUVASTATINUM+EZETIMIBUM) | CAPS. | C10BA06 | W61295001 | EGIS PHARMACEUTICALS PLC - UNGARIA | ||||||
| LIPOCOMB 20 mg/10 mg | COMBINATII (ROSUVASTATINUM+EZETIMIBUM) | CAPS. | C10BA06 | W61295002 | EGIS PHARMACEUTICALS PLC - UNGARIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman